Učitavanje...

Design of a randomized controlled trial of disclosing genomic risk of coronary heart disease: the Myocardial Infarction Genes (MI-GENES) study

BACKGROUND: Whether disclosure of a genetic risk score (GRS) for a common disease influences relevant clinical outcomes is unknown. We describe design of the Myocardial Infarction Genes (MI-GENES) Study, a randomized clinical trial to assess whether disclosing a GRS for coronary heart disease (CHD)...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMC Med Genomics
Glavni autori: Kullo, Iftikhar J., Jouni, Hayan, Olson, Janet E., Montori, Victor M., Bailey, Kent R.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2015
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4536729/
https://ncbi.nlm.nih.gov/pubmed/26271327
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12920-015-0122-0
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!